-
EP3676277
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3676277
| EP3676277 - CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 26.02.2021 Database last updated on 18.01.2025 | |
| Former | Request for examination was made Status updated on 05.06.2020 | ||
| Former | The international publication has been made Status updated on 08.03.2019 | ||
| Former | unknown Status updated on 22.09.2018 | Most recent event Tooltip | 05.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2020/28] | Inventor(s) | 01 /
HARIKRISHNAN, Lalgudi S. c/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton New Jersey 08543 / US | 02 /
KAMAU, Muthoni G. c/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton New Jersey 08543 / US | 03 /
ZHU, Xiao 4 Valleywood Circle Winchester, MA 01890 / US | [2020/28] | Representative(s) | Kling, Edouard Swords Laboratories, Ireland Swiss Branch, Steinhausen Hinterbergstrasse 16 6312 Steinhausen / CH | [2020/28] | Application number, filing date | 18766540.1 | 30.08.2018 | [2020/28] | WO2018US48658 | Priority number, date | US201762552701P | 31.08.2017 Original published format: US 201762552701 P | [2020/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019046496 | Date: | 07.03.2019 | Language: | EN | [2019/10] | Type: | A1 Application with search report | No.: | EP3676277 | Date: | 08.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.03.2019 takes the place of the publication of the European patent application. | [2020/28] | Search report(s) | International search report - published on: | EP | 07.03.2019 | Classification | IPC: | C07H21/02, A61P35/00 | [2020/28] | CPC: |
C07H21/02 (EP,KR,US);
A61K31/7052 (KR);
A61P35/00 (EP,KR);
C07H21/00 (EP);
C07K16/2818 (US);
A61K2039/505 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/28] | Title | German: | CYCLISCHE DINUKLEOTIDE ALS ANTIKREBSMITTEL | [2020/28] | English: | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | [2020/28] | French: | DINUCLÉOTIDES CYCLIQUES UTILISÉS EN TANT QU'AGENTS ANTICANCÉREUX | [2020/28] | Entry into regional phase | 05.03.2020 | National basic fee paid | 05.03.2020 | Designation fee(s) paid | 05.03.2020 | Examination fee paid | Examination procedure | 05.03.2020 | Examination requested [2020/28] | 05.03.2020 | Date on which the examining division has become responsible | 08.10.2020 | Amendment by applicant (claims and/or description) | 26.02.2021 | Despatch of a communication from the examining division (Time limit: M04) | 30.06.2021 | Reply to a communication from the examining division | Fees paid | Renewal fee | 13.08.2020 | Renewal fee patent year 03 | 13.08.2021 | Renewal fee patent year 04 | 15.07.2022 | Renewal fee patent year 05 | 13.07.2023 | Renewal fee patent year 06 | 04.07.2024 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2016120305 (GLAXOSMITHKLINE IP DEV LTD [GB]); | [A]WO2017123657 (GLICK GARY [US], et al); | [YP]WO2018045204 (IFM THERAPEUTICS INC [US]); | [YP]WO2018118665 (MERCK SHARP & DOHME [US], et al) | by applicant | WO2006029879 | WO2006105021 | WO2006122150 | WO2007075598 | WO2008036653 | WO2008036642 | WO2008132601 | WO2009009116 | WO2009044273 | WO2009073620 | WO2010019570 | WO2011028683 | WO2011056652 | WO2011070024 | WO2011107553 | WO2011109400 | WO2011131407 | WO2011140249 | WO2012032433 | WO2012142237 | WO2012145493 | WO2013087699 | WO2013119716 | WO2013132044 | WO2013169264 | WO2013181634 | WO2014008218 | WO2014036357 | WO2014179664 | WO2014194302 | WO2015035606 | WO2015085847 | WO2015112900 | WO2015112800 | WO2016149201 |